Want to join the conversation?
$BDX 3Q15 Call: Pricing was about flat on a legacy BD basis. YTD pricing is better than our expectations,& as such we are revising our full year guidance for pricing to be about flat YoverY. BD Medical third quarter revenues increased 1.6%. Underlying medical revenue growth was approx. 4%, which includes normalizing for tough comparison in Infusion
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!